Answer to the Letter to the Editor

References

• 1 Cavaliere1  R, Schiff1  D. Donor transmission of primary brain tumor: A neuro-oncologic perspective.  Transplantation Reviews. 2004;  18 204-213
• 2 Kauffman HM. The United Network for Organ Sharing position on using donors with primary central nervous system malignancies.  Transplantation. 2005;  79 622-623
• 3 Köhler S, Ullrich S, Richter U. et al . P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung.  Br J Cancer.. 2010;  102 602-609 Epub 2009 Dec 15
• 4 Merchant TE, Pollack IF, Loeffler JS. Brain tumors across the age spectrum: biology, therapy, and late effects.  Semin Radiat Oncol. 2010;  20 58-66
• 5 Milde T, Oehme I, Pfister S. et al . Histone deacetylases 5 and 9 are novel markers for medulloblastoma risk stratification and potential drug targets for therapy.  Klin Padiatr. 2009;  221 202-203
• 6 Rey JW, Heister P, Wirges U. et al . Organ donor with unclear primary brain tumor, a contraindication for transplantation? Case report of an one year old child.  Klin Padiatr. 2009;  221 390-392
• 7 Rutkowski S, Bode U, Deinlein F. et al . Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.  N Engl J Med. 2005;  352 978-986
• 8 Wendland MM, Shrieve DC, Watson GA. et al . Extraneural metastatic medulloblastoma in an adult.  J Neurooncol. 2006;  78 191-196 Epub 2006 Apr 6.
• 9 Wolff JE, Classen CF, Wagner S. et al . Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database.  J Neurooncol. 2008;  87 155-164 Epub 2008 Jan 22